Your Messages Inbox
Your Article Summary
See Latest ArticlesTeva Announces Approval and Launch of Geveric Solodyn Extended-Release Tablets
Teva Pharmaceutical Industries, 03/23/09
Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application to market its generic version of Medicis Pharmaceutical Corporation's acne treatment Solodyn Extended-Release Tablets, 45 mg, 90 mg and 135 mg. Shipment of this product has commenced.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor